HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.

Abstract
Indolizine and annulated indolizine derivatives incorporating a cyclopropylcarbonyl group were synthesized in a one pot procedure by the tanden reactions of [3+2] cycloaddition of the corresponding N-ylide with electron deficient alkene. Seventeen indolizine derivatives were reported for the first time. All the compounds were examined for their antiproliferative activity against the human hepatocellular liver carcinoma (Hep-G2) cell line by MTT method. Among the compounds tested, 5a, 5d, 5 g and 5 j showed the most favorable activities with IC(50) values of 0.39, 0.48, 0.29 and 0.20 microg/mL. Especially, compound 5 j displayed potent antiproliferative activities with IC(50) value of 0.20 microg/mL, and showed significant EGFR kinase inhibitory activity with IC(50) value of 0.085 microM. Docking simulations of 5 j were carried out to illustrate the binding mode of the molecular into the EGFR active site.
AuthorsYong-Miao Shen, Peng-Cheng Lv, Wu Chen, Peng-Gang Liu, Ming-Zhu Zhang, Hai-Liang Zhu
JournalEuropean journal of medicinal chemistry (Eur J Med Chem) Vol. 45 Issue 7 Pg. 3184-90 (Jul 2010) ISSN: 1768-3254 [Electronic] France
PMID20304535 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2010 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Antineoplastic Agents
  • Indolizines
  • indolizine
  • ErbB Receptors
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, metabolism, pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • ErbB Receptors (chemistry, metabolism)
  • Humans
  • Indolizines (chemical synthesis, chemistry, metabolism, pharmacology)
  • Inhibitory Concentration 50
  • Models, Molecular
  • Molecular Conformation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: